Anne Douar, Chief Development Officer of Vivet Therapeutics, will give a presentation
VIVET ATTENDING CHARDAN'S 4th ANNUAL GENETIC MEDICINES CONFERENCE
VIVET ATTENDING THE HEALTHTECH INNOVATION DAYS (HTID) IN PARIS
Bernard Benichou Vivet Therapeutics' CMO will be participating to a panel and Jean-Philippe Combal, CEO and Sonia Valero, Head of Clinical Operations…
Vivet Therapeutics, a privately held gene therapy biotech company
Vivet Therapeutics' CEO, Jean-Philippe Combal
Jean-Philippe Combal, Vivet Therapeutics' CEO, and Thomas Daniel, BD Director, will be hosting 1x1 meetings during
Vivet Therapeutics CEO, Jean-Philippe Combal
Dr. Gloria González-Aseguinolaza, Vivet Therapeutics CSO